Technique training does not improve the ability of most patients to use pressurised metered-dose inhalers (pMDIs)

Primary Care Respiratory Journal

Volumn 20, Issue 1, 2011, Pages 92-96

  Hardwell, Alison ^a   Barber, Victoria ^b   Hargadon, Tina ^b   McKnight, Eddie ^b   Holmes, John ^c   Levy, Mark L ^d  

^a National Services for Health Improvement (NSHI)   (United Kingdom)

^b Magister Consulting   (United Kingdom)

^c Teva UK Limited   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Asthma; Education; Inhaler technique; Management; Nurse; Observational; pMDI; Primary care; Treatment

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;

AGE; ASTHMA; CONTROLLED STUDY; DISEASE CONTROL; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; METERED DOSE INHALER; MONITOR; NURSING PRACTICE; PATIENT ASSESSMENT; PATIENT ATTITUDE; PATIENT EDUCATION; PATIENT MONITORING; PRESCRIPTION; PRESSURISED METERED DOSE INHALER; QUESTIONNAIRE; REVIEW; SYMPTOMATOLOGY; TRAINING;

EID: 80053050503     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2010.00088     Document Type: Review

References (18)

1. British Thoracic Society, Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma. Thorax 2008;63(Supplement 4):iv1- iv121. [Accessed 18/11/2010] Available from: http://dx.doi.org/ http://www.sign.ac.uk/guidelines/fulltext/101/index.html
2. The Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) Updated 2008. 2008 [Last Accessed 18/11/2010]; Available from: http://www.ginasthma.org;
3. Crompton GK. Problems patients have using pressurized aerosol inhalers. Eur J Resp Diseases 1982; 63(Suppl.119):101-04.
4. Giraud V, Roche N. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J 2002;19(2):246-51. http://dx.doi.org/10.1183/09031936.02.00218402
5. Van Beerendonk I, Mesters I, Mudde AN, Tan TD. Assessment of the inhalation technique in outpatients with asthma or chronic obstructive pulmonary disease using a metered-dose inhaler or dry powder device. Journal of Asthma 1998;35(3):273-9. http://dx.doi.org/10.3109/02770909809068218
6. Hanania NA, Wittman R, Kesten S, Chapman KR. Medical personnel's knowledge of and ability to use inhaling devices: Metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers. Chest 1994;105(1):111-16.
7. MIQUEST. [Last Accessed: 4/4/2010]; Available from: http://www.connectingforhealth.nhs.uk/systemsandservices/ssd/prodserv/vapordmiquest/?searchterm=miquest;
8. Bucknall CE, Ryland I, Cooper A, Coutts, II, Connolly CK, Pearson MG. National benchmarking as a support system for clinical governance. J R Coll Physicians Lond 2000;34(1):52-6.
9. Skaer TL, Wilson CB, Sclar DA, et al. Metered-dose inhaler technique and quality of life with airways disease: Assessing the value of the vitalograph in educational intervention. J Int Med Research 1996;24(4):369-75.
10. Sarvis CA, Tice AL, Plake KS. Evaluation of inhaler technique using the aerosol inhalation monitor. J Pharm Practice 2004;17(4):275-9. http://dx.doi.org/10.1177/0897190004270027
11. Nursing and Midwifery Council. Standards of conduct, performance and ethics for nurses and midwives. [Last Accessed: 4/4/2010]; Available from: http://www.nmc-uk.org/aArticle.aspx?ArticleID=3056;
12. The Association of the British Pharmaceutical Industry (ABPI) Code of Practice. [Last Accessed: 4/4/2010]; Available from: http://www.abpi.org.uk/ publications/pdfs/pmpca_code2008.pdf;
13. The Caldicott Committee. Report on the Review of Patient-Identifiable Information. 1997 [Last Accessed: 4/4/2010]; Available from: http://www.wales.nhs.uk/sites3/Documents/783/DH%5F4068404%5B1%5D.pdf
14. UK Data Protection Act. 1998 [Last Accessed: 4/4/2010]; Available from: http://www.opsi.gov.uk/acts/acts1998/ukpga_19980029_en_1;
15. Virchow JC, Crompton GK, Dal Negro R, et al. Importance of inhaler devices in the management of airway disease. Resp Med 2008;102(1):10-19. http://dx.doi.org/10.1016/j.rmed.2007.07.031
16. Broeders MEAC, Sanchis J, Levy ML, Crompton GK, Dekhuijzen PNR, on behalf of the ADMIT Working Group. The ADMIT series - Issues in Inhalation Therapy. 2) Improving technique and clinical effectiveness. Prim Care Respir J 2009;18(2):76-82. http://dx.doi.org/10.4104/pcrj.2009.00025
17. Lavorini F, Levy ML, Corrigan C, Crompton G, on behalf of the ADMIT Working Group. The ADMIT series - Issues in Inhalation Therapy. 6) Training tools for inhalation devices. Prim Care Respir J 2010;19(4):335-41. http://dx.doi.org/10.4104/pcrj.2010.00065
18. Vincken W, Dekhuijzen PNR, Barnes P, on behalf of the ADMIT Group. The ADMIT series-Issues in Inhalation Therapy. 4) How to choose inhaler devices for the treatment of COPD. Prim Care Respir J 2010;19(1):10-20. http://dx.doi.org/10.4104/pcrj.2009.00062